|
1.Hepatitis B
vaccine (HepB).
• Administer the 3-dose series to those who were not
previously vaccinated.
• A 2-dose series of Recombivax HB® is licensed for children
aged 11–15 years.
2. Rotavirus vaccine
(Rota).
• Do not start the series later than
age 12 weeks.
• Administer the final dose in the series by age 32 weeks.
• Do not administer a dose later than age 32 weeks.
• Data on safety and efficacy outside of these age ranges are
insufficient.
3. Diphtheria and tetanus toxoids and acellular pertussis
vaccine (DTaP).
• The fifth dose is not necessary if the fourth dose was
administered at age 4 years or older.
• DTaP is not indicated for persons aged 7 years or older.
4. Haemophilus influenzae type b conjugate vaccine (Hib).
• Vaccine is not generally recommended for children aged 5 years
or older.
• If current age is younger than 12 months and the first 2 doses
were PRP-OMP (PedvaxHIB® or ComVax® [Merck]), the third (and
final) dose should be administered at age 12–15 months and at
least 8 weeks after the second dose.
• If first dose was administered at age 7–11 months, administer
2 doses separated by 4 weeks plus a booster at age 12–15 months.
5.
Pneumococcal conjugate vaccine (PCV).
• Administer one dose of PCV to all healthy children aged 24–59
months having any incomplete schedule.
• For children with underlying medical conditions administer 2
doses of PCV at least 8 weeks apart if previously received less
than 3 doses or 1 dose of PCV if previously received 3 doses.
6.
Inactivated poliovirus vaccine (IPV).
• For children who received an all-IPV or all-oral poliovirus (OPV)
series, a fourth dose is not necessary if third dose was
administered at age 4 years or older.
• If both OPV and IPV were administered as part of a series, a
total of 4 doses should be administered, regardless of the
child’s current age.
• IPV is not routinely recommended for persons aged 18 years and
older.
7.
Measles, mumps, and rubella vaccine (MMR).
• The second dose of MMR is recommended routinely at age 4–6
years but may be administered earlier if desired.
• If not previously vaccinated, administer 2 doses of MMR during
any visit with 4 or more weeks between the doses.
8. Varicella vaccine.
• The second dose of varicella vaccine is recommended routinely
at age 4–6 years but may be administered earlier if desired.
• Do not repeat the second dose in persons younger than 13 years
of age if administered 28 or more days after the first dose.
9. Hepatitis A vaccine
(HepA).
• HepA is recommended for certain groups of children, including
in areas where vaccination programs target older children. See
MMWR 2006;55(No. RR-7):1–23.
10. Tetanus and diphtheria toxoids vaccine (Td) and tetanus and
diphtheria toxoids and acellular pertussis vaccine (Tdap).
• Tdap should be substituted for a single dose of Td in the
primary catch-up series or as a booster if age appropriate; use
Td for other doses.
• A 5-year interval from the last Td dose is encouraged when
Tdap is used as a booster dose. A booster (fourth) dose is
needed if any of the previous doses were administered at younger
than 12 months of age. Refer to ACIP recommendations for further
information.
See MMWR 2006;55(No. RR-3).
11. Human
papillomavirus vaccine (HPV).
• Administer the HPV vaccine series to females at age 13–18
years if not previously vaccinated.
|
